T1	chemical 4 8	mRNA
T2	disease_or_phenotypic_feature 150 164	PAM50-subtypic
T3	chemical 193 205	drug-induced
T4	missed_disease_or_phenotypic_feature 206 209	PLG
T5	chemical 242 265	immunosuppressive agent
T6	chemical 270 274	lead
T7	disease_or_phenotypic_feature 278 285	disease
T8	chemical 359 368	biomarker
T9	disease_or_phenotypic_feature 380 383	HCC
T10	chemical 486 497	adiponectin
T11	disease_or_phenotypic_feature 524 528	GDM.
T12	disease_or_phenotypic_feature 593 617	hepatocellular carcinoma
T13	chemical 656 666	biomarkers
T14	chemical 745 757	Somatostatin
T15	disease_or_phenotypic_feature 832 841	disorders
T16	disease_or_phenotypic_feature 985 993	AEL)/CEL
T17	chemical 1043 1052	cosmetics
T18	chemical 1161 1170	cosmetics
T19	chemical 1261 1268	peptide
T20	disease_or_phenotypic_feature 1282 1287	IPS-1
T21	disease_or_phenotypic_feature 1388 1394	common
T22	chemical 1423 1434	rivaroxaban
T23	chemical 1456 1464	warfarin
T24	disease_or_phenotypic_feature 1538 1541	PCa
T25	chemical 1542 1551	biomarker
T26	disease_or_phenotypic_feature 1651 1679	benign prostatic hyperplasia
T27	disease_or_phenotypic_feature 1684 1699	prostate cancer
T28	chemical 1722 1737	silver-nanowire
T29	chemical 1801 1809	electron
T30	disease_or_phenotypic_feature 1893 1902	sensitive
T31	chemical 2041 2051	biological
T32	disease_or_phenotypic_feature 2052 2058	injury
T33	chemical 2196 2203	thyroid
T34	disease_or_phenotypic_feature 2196 2213	thyroid carcinoma
T35	chemical 2241 2250	cisplatin
T36	missed_chemical 2252 2256	CDDP
T38	corrected_chemical 2283 2304	chemotherapeutic drug
T39	chemical 2300 2304	drug
T40	disease_or_phenotypic_feature 2309 2346	head and neck squamous cell carcinoma
T41	disease_or_phenotypic_feature 2348 2354	HNSCC)
T42	disease_or_phenotypic_feature 2441 2450	materials
T43	chemical 2456 2469	nanoparticles
T44	disease_or_phenotypic_feature 2494 2503	materials
T45	disease_or_phenotypic_feature 2538 2547	fractions
T46	disease_or_phenotypic_feature 2779 2782	CKD
T47	chemical 2783 2788	group
T48	chemical 2816 2827	cholesterol
T49	chemical 2838 2843	group
T50	disease_or_phenotypic_feature 2946 2952	cancer
T51	chemical 3012 3022	biological
T52	chemical 3287 3297	ivermectin
T53	disease_or_phenotypic_feature 3364 3371	disease
T54	chemical 3465 3475	nucleotide
T55	disease_or_phenotypic_feature 3546 3559	breast cancer
T56	chemical 3733 3740	Cr-EDTA
T57	disease_or_phenotypic_feature 3798 3805	CKD-EPI
R2	causes_or_contributes_to Arg1:T5 Arg2:T4
R3	FIXME Arg1:T38 Arg2:T40
R4	treats Arg1:T52 Arg2:T53
R6	treats Arg1:T35 Arg2:T40
R7	FIXME Arg1:T35 Arg2:T41
R8	FIXME Arg1:T35 Arg2:T40
R9	treats Arg1:T36 Arg2:T40
T58	corrected_chemical 193 197	drug
R10	causes_or_contributes_to Arg1:T58 Arg2:T4	
T59	corrected_disease_or_phenotypic_feature 2348 2353	HNSCC
R5	treats Arg1:T38 Arg2:T40	
R11	treats Arg1:T38 Arg2:T59	
R12	treats Arg1:T35 Arg2:T59	
R13	treats Arg1:T36 Arg2:T59	
T37	missed_chemical 3239 3256	gametocidal drugs
R14	treats Arg1:T37 Arg2:T53	
R1	treats Arg1:T5 Arg2:T7	
T60	missed_disease_or_phenotypic_feature 1121 1136	skin sensitizer
T61	missed_chemical 1095 1103	CMIT/MIT
R15	causes_or_contributes_to Arg1:T61 Arg2:T60	
